NCT04579497

Brief Summary

A study to explore whether different temperatures of warm water footbaths have different effects on the cardiovascular system, the autonomic nervous system and the general well-being of healthy women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 8, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

October 26, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

July 16, 2021

Status Verified

July 1, 2021

Enrollment Period

7 months

First QC Date

September 29, 2020

Last Update Submit

July 15, 2021

Conditions

Keywords

Warm water footbathTemperature-dependent effectsCardiovascular SystemAutonomic Nervous SystemHeart Rate VariabilityHealthy female volunteers

Outcome Measures

Primary Outcomes (1)

  • Pressure Rate Product (PRP) at timepoint t5 (footbath minute 21-30)

    Pressure Rate Product (PRP), calculated from systolic blood pressure (measured with the Mobil-O-Graph® PWA) and heart rate (measured with the Bittium Faros 360TM ECG recorder) at timepoint 5 (t5 = mean of the measurements recorded from minute 21 to minute 30 of the footbath).

    Timepoint 5 (t5 = mean of the measurements recorded from minute 21-30 of the 30-minute footbath)

Secondary Outcomes (52)

  • Change in Pressure Rate Product (PRP) at timepoints t1 (minute 1-10 of the pre-intervention rest period), t3 (minute 1-10 of the footbath), t4 (minute 11-20 of the footbath), and t7 (minute 1-10 of the post-intervention rest period).

    Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.

  • Heart rate variability (HRV) analysis: Change in SDNN

    Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.

  • Change in pNN50

    Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.

  • Change in HF

    Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.

  • Change in LF

    Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.

  • +47 more secondary outcomes

Other Outcomes (2)

  • Change in warmth perception and skin stimulus at the feet during the footbath

    Up to 30 minutes.

  • Preferred footbath

    10 minutes.

Study Arms (4)

38° C footbath

EXPERIMENTAL

Footbath with warm water at a constant temperature of 38° C

Other: 38°C warm water footbath

40° C footbath

EXPERIMENTAL

Footbath with warm water at a constant temperature of 40° C

Other: 40°C warm water footbath

42° C footbath

EXPERIMENTAL

Footbath with warm water at a constant temperature of 42° C

Other: 42°C warm water footbath

Rising temperature footbath

EXPERIMENTAL

Footbath with warm water rising from 38° C to 42° C

Other: 38-42°C rising temperature footbath

Interventions

A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water at a constant temperature of 38°C, followed by a ten-minute post-intervention rest period.

38° C footbath

A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water at a constant temperature of 40°C, followed by a ten-minute post-intervention rest period.

40° C footbath

A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water at a constant temperature of 42°C, followed by a ten-minute post-intervention rest period.

42° C footbath

A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water. Water temperature starts at 38°C and is increased by 1°C every 6 minutes, resulting in 42°C after 30 minutes. The footbath is followed by a ten-minute post-intervention rest period.

Rising temperature footbath

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Written informed consent
  • Age between 18 and 55 years

You may not qualify if:

  • Male sex
  • Chronic skin lesions at the lower legs or feet
  • Varicose veins grade 3 and grade 4 (Marshall stage classification), chronic venous insufficiency
  • Cardiac arrhythmia
  • Cardiac pacemaker
  • Asthma bronchiale
  • Consumption of HRV-modulating medication (especially tricyclic antidepressants, beta blockers)
  • Pregnancy
  • Insufficient knowledge of the German language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arcim Institute

Filderstadt, Baden-Wurttemberg, 70794, Germany

Location

Study Officials

  • Jan Vagedes, Dr

    Arcim Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2020

First Posted

October 8, 2020

Study Start

October 26, 2020

Primary Completion

May 31, 2021

Study Completion

May 31, 2021

Last Updated

July 16, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
The data will be made available upon publication for a duration of three months.
Access Criteria
The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.

Locations